237 related articles for article (PubMed ID: 36873421)
1. Impact of ammonia levels on outcome in clinically stable outpatients with advanced chronic liver disease.
Balcar L; Krawanja J; Scheiner B; Paternostro R; Simbrunner B; Semmler G; Jachs M; Hartl L; Stättermayer AF; Schwabl P; Pinter M; Szekeres T; Trauner M; Reiberger T; Mandorfer M
JHEP Rep; 2023 Apr; 5(4):100682. PubMed ID: 36873421
[TBL] [Abstract][Full Text] [Related]
2. Factor VIII/protein C ratio independently predicts liver-related events but does not indicate a hypercoagulable state in ACLD.
Scheiner B; Balcar L; Nussbaumer RJ; Weinzierl J; Paternostro R; Simbrunner B; Hartl L; Jachs M; Bauer D; Stättermayer AF; Semmler G; Pinter M; Ay C; Quehenberger P; Trauner M; Reiberger T; Lisman T; Mandorfer M
J Hepatol; 2022 May; 76(5):1090-1099. PubMed ID: 35066090
[TBL] [Abstract][Full Text] [Related]
3. An impaired pituitary-adrenal signalling axis in stable cirrhosis is linked to worse prognosis.
Hartl L; Simbrunner B; Jachs M; Wolf P; Bauer DJM; Scheiner B; Balcar L; Semmler G; Schwarz M; Marculescu R; Trauner M; Mandorfer M; Reiberger T
JHEP Rep; 2023 Aug; 5(8):100789. PubMed ID: 37484210
[TBL] [Abstract][Full Text] [Related]
4. Lower free triiodothyronine (fT3) levels in cirrhosis are linked to systemic inflammation, higher risk of acute-on-chronic liver failure, and mortality.
Hartl L; Simbrunner B; Jachs M; Wolf P; Bauer DJM; Scheiner B; Balcar L; Semmler G; Schwarz M; Marculescu R; Dannenberg V; Trauner M; Mandorfer M; Reiberger T
JHEP Rep; 2024 Jan; 6(1):100954. PubMed ID: 38125301
[TBL] [Abstract][Full Text] [Related]
5. Systemic inflammation increases across distinct stages of advanced chronic liver disease and correlates with decompensation and mortality.
Costa D; Simbrunner B; Jachs M; Hartl L; Bauer D; Paternostro R; Schwabl P; Scheiner B; Stättermayer AF; Pinter M; Trauner M; Mandorfer M; Reiberger T
J Hepatol; 2021 Apr; 74(4):819-828. PubMed ID: 33075344
[TBL] [Abstract][Full Text] [Related]
6. Decreasing von Willebrand Factor Levels Upon Nonselective Beta Blocker Therapy Indicate a Decreased Risk of Further Decompensation, Acute-on-chronic Liver Failure, and Death.
Jachs M; Hartl L; Simbrunner B; Bauer D; Paternostro R; Scheiner B; Schwabl P; Stättermayer AF; Pinter M; Eigenbauer E; Quehenberger P; Trauner M; Reiberger T; Mandorfer M
Clin Gastroenterol Hepatol; 2022 Jun; 20(6):1362-1373.e6. PubMed ID: 34256145
[TBL] [Abstract][Full Text] [Related]
7. Alpha-1 antitrypsin Pi∗Z allele is an independent risk factor for liver transplantation and death in patients with advanced chronic liver disease.
Balcar L; Scheiner B; Urheu M; Weinberger P; Paternostro R; Simbrunner B; Hartl L; Jachs M; Bauer D; Semmler G; Willheim C; Pinter M; Ferenci P; Trauner M; Reiberger T; Stättermayer AF; Mandorfer M
JHEP Rep; 2022 Nov; 4(11):100562. PubMed ID: 36176936
[TBL] [Abstract][Full Text] [Related]
8. Von Willebrand factor for outcome prediction within different clinical stages of advanced chronic liver disease.
Dominik N; Scheiner B; Zanetto A; Balcar L; Semmler G; Campello E; Schwarz M; Paternostro R; Simbrunner B; Hofer BS; Stättermayer AF; Pinter M; Trauner M; Quehenberger P; Simioni P; Reiberger T; Mandorfer M
Aliment Pharmacol Ther; 2024 Jun; 59(11):1376-1386. PubMed ID: 38482706
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of substantially elevated von Willebrand factor antigen levels in patients with advanced chronic liver disease.
Pomej K; Scheiner B; Balcar L; Nussbaumer RJ; Weinzierl J; Paternostro R; Simbrunner B; Bauer D; Pereyra D; Starlinger P; Stättermayer AF; Pinter M; Trauner M; Quehenberger P; Reiberger T; Mandorfer M
Dig Liver Dis; 2022 Oct; 54(10):1376-1384. PubMed ID: 35871985
[TBL] [Abstract][Full Text] [Related]
10. Risk of further decompensation/mortality in patients with cirrhosis and ascites as the first single decompensation event.
Balcar L; Tonon M; Semmler G; Calvino V; Hartl L; Incicco S; Jachs M; Bauer D; Hofer BS; Gambino CG; Accetta A; Brocca A; Trauner M; Mandorfer M; Piano S; Reiberger T;
JHEP Rep; 2022 Aug; 4(8):100513. PubMed ID: 35845294
[TBL] [Abstract][Full Text] [Related]
11. Plasma ammonia levels predict hospitalisation with liver-related complications and mortality in clinically stable outpatients with cirrhosis.
Tranah TH; Ballester MP; Carbonell-Asins JA; Ampuero J; Alexandrino G; Caracostea A; Sánchez-Torrijos Y; Thomsen KL; Kerbert AJC; Capilla-Lozano M; Romero-Gómez M; Escudero-García D; Montoliu C; Jalan R; Shawcross DL
J Hepatol; 2022 Dec; 77(6):1554-1563. PubMed ID: 35872326
[TBL] [Abstract][Full Text] [Related]
12. Hepatic venous pressure gradient predicts risk of hepatic decompensation and liver-related mortality in patients with MASLD.
Paternostro R; Kwanten WJ; Hofer BS; Semmler G; Bagdadi A; Luzko I; Hernández-Gea V; Graupera I; García-Pagán JC; Saltini D; Indulti F; Schepis F; Moga L; Rautou PE; Llop E; Téllez L; Albillos A; Fortea JI; Puente A; Tosetti G; Primignani M; Zipprich A; Vuille-Lessard E; Berzigotti A; Taru MG; Taru V; Procopet B; Jansen C; Praktiknjo M; Gu W; Trebicka J; Ibanez-Samaniego L; Bañares R; Rivera-Esteban J; Pericas JM; Genesca J; Alvarado E; Villanueva C; Larrue H; Bureau C; Laleman W; Ardevol A; Masnou H; Vanwolleghem T; Trauner M; Mandorfer M; Francque S; Reiberger T;
J Hepatol; 2024 May; ():. PubMed ID: 38823501
[TBL] [Abstract][Full Text] [Related]
13. von Willebrand factor as new noninvasive predictor of portal hypertension, decompensation and mortality in patients with liver cirrhosis.
Ferlitsch M; Reiberger T; Hoke M; Salzl P; Schwengerer B; Ulbrich G; Payer BA; Trauner M; Peck-Radosavljevic M; Ferlitsch A
Hepatology; 2012 Oct; 56(4):1439-47. PubMed ID: 22532296
[TBL] [Abstract][Full Text] [Related]
14. Von Willebrand factor processing in patients with advanced chronic liver disease and its relation to portal hypertension and clinical outcome.
Simbrunner B; Villesen IF; Scheiner B; Paternostro R; Schwabl P; Stättermayer AF; Marculescu R; Pinter M; Quehenberger P; Trauner M; Karsdal M; Lisman T; Reiberger T; Leeming DJ; Mandorfer M
Hepatol Int; 2023 Dec; 17(6):1532-1544. PubMed ID: 37605068
[TBL] [Abstract][Full Text] [Related]
15. Alcohol Abstinence Improves Prognosis Across All Stages of Portal Hypertension in Alcohol-Related Cirrhosis.
Hofer BS; Simbrunner B; Hartl L; Jachs M; Bauer DJM; Balcar L; Paternostro R; Schwabl P; Semmler G; Scheiner B; Staettermayer AF; Trauner M; Mandorfer M; Reiberger T
Clin Gastroenterol Hepatol; 2023 Aug; 21(9):2308-2317.e7. PubMed ID: 36481475
[TBL] [Abstract][Full Text] [Related]
16. Dysregulated biomarkers of innate and adaptive immunity predict infections and disease progression in cirrhosis.
Simbrunner B; Hartl L; Jachs M; Bauer DJM; Scheiner B; Hofer BS; Stättermayer AF; Marculescu R; Trauner M; Mandorfer M; Reiberger T
JHEP Rep; 2023 May; 5(5):100712. PubMed ID: 37035457
[TBL] [Abstract][Full Text] [Related]
17. Balance between macrophage migration inhibitory factor and sCD74 predicts outcome in patients with acute decompensation of cirrhosis.
Wirtz TH; Reuken PA; Jansen C; Fischer P; Bergmann I; Backhaus C; Emontzpohl C; Reißing J; Brandt EF; Koenen MT; Schneider KM; Schierwagen R; Brol MJ; Chang J; Zimmermann HW; Köse-Vogel N; Eggermann T; Kurth I; Stoppe C; Bucala R; Bernhagen J; Praktiknjo M; Stallmach A; Trautwein C; Trebicka J; Bruns T; Berres ML
JHEP Rep; 2021 Apr; 3(2):100221. PubMed ID: 33659891
[TBL] [Abstract][Full Text] [Related]
18. Systemic inflammation is linked to liver fibrogenesis in patients with advanced chronic liver disease.
Simbrunner B; Villesen IF; Königshofer P; Scheiner B; Bauer D; Paternostro R; Schwabl P; Timelthaler G; Ramazanova D; Wöran K; Stift J; Eigenbauer E; Stättermayer AF; Marculescu R; Pinter M; Møller S; Trauner M; Karsdal M; Leeming DJ; Reiberger T; Mandorfer M
Liver Int; 2022 Nov; 42(11):2501-2512. PubMed ID: 35822301
[TBL] [Abstract][Full Text] [Related]
19. Amelioration of systemic inflammation in advanced chronic liver disease upon beta-blocker therapy translates into improved clinical outcomes.
Jachs M; Hartl L; Schaufler D; Desbalmes C; Simbrunner B; Eigenbauer E; Bauer DJM; Paternostro R; Schwabl P; Scheiner B; Bucsics T; Stättermayer AF; Pinter M; Trauner M; Mandorfer M; Reiberger T
Gut; 2021 Sep; 70(9):1758-1767. PubMed ID: 33199442
[TBL] [Abstract][Full Text] [Related]
20. Non-invasive detection of portal hypertension by enhanced liver fibrosis score in patients with different aetiologies of advanced chronic liver disease.
Simbrunner B; Marculescu R; Scheiner B; Schwabl P; Bucsics T; Stadlmann A; Bauer DJM; Paternostro R; Eigenbauer E; Pinter M; Stättermayer AF; Trauner M; Mandorfer M; Reiberger T
Liver Int; 2020 Jul; 40(7):1713-1724. PubMed ID: 32358998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]